Add like
Add dislike
Add to saved papers

Octakis(2-pyridyl)porphyrazine and Its Neutral Metal Derivatives: UV-Visible Spectral, Electrochemical, and Photoactivity Studies.

Tetrapyrrolic porphyrazine macrocycles with externally appended 2-pyridyl rings were synthesized and characterized as to their spectroscopic, electrochemical, and photophysical properties. The investigated compounds are represented as [Py8 PzH2 ], the unmetalated octakis(2-pyridyl)porphyrazine, and the metal complexes [Py8 PzM], where M is MgII (H2 O), CuII , ZnII , or CoII . The spectroscopic properties and the electrochemical behavior of these compounds were examined in solution of polar (pyridine, dimethyl sulfoxide, and dimethylformamide) and nondonor solvents (CHCl3 , CH2 Cl2 ), and the data were compared with those obtained from earlier studies on the related tetrapyrazinoporphyrazines, [Py8 TPyzPzM], and the tetraquinoxalinoporphyrazines, [Py8 QxPzM], also bearing externally 2-pyridyl rings, and characterized by a more extended central π-conjugated macrocyclic framework. The newly synthesized porphyrazines possess good solubility and are present in their monomeric form in all the examined solvents as shown by UV-visible spectra. The unmetalated species and metal derivatives undergo multiple one-electron reductions within the potential range of the nonaqueous examined solvents. The derivatives with nonredox active metal centers could accept four electrons on the conjugated macrocycle, while the CoII complex was characterized by a single one-electron oxidation and five reductions in DMSO. The photosensitizer activity for the generation of singlet oxygen was also examined for the MgII (H2 O) and ZnII complexes in DMF, with measured ΦΔ values being, respectively, 0.42 and 0.64, this latter value indicating the ZnII species as being a promising material for use as anticancer agent in photodynamic therapy.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app